Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment Performance

Analytics

N/A
12(100.0%)
12Total
N/A(12)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT03349996Not ApplicableCompleted

Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions

Role: lead

NCT07010354Recruiting

An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow

Role: collaborator

NCT03347383Not ApplicableCompleted

Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions

Role: lead

NCT03845543Not ApplicableCompleted

Belgian-Italian Trial to Evaluate the Efficacy and Safety of Below The Knee (BTK) Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular

Role: lead

NCT03884257Not ApplicableActive Not Recruiting

A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.

Role: lead

NCT05293002Not ApplicableActive Not Recruiting

Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.

Role: lead

NCT03286361Not ApplicableActive Not Recruiting

Clinical Trial Investigating the BeGraft Peripheral Plus Stent Graft System for Iliac Lesion Treatment

Role: lead

NCT03368144Not ApplicableCompleted

Belgian Trial Evaluating the ClearLumen II Peripheral Thrombectomy System Recanalization of (sub)acute Thrombotic Femoropopliteal Occlusions

Role: lead

NCT04349657Not ApplicableRecruiting

A Study Evaluating the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy

Role: lead

NCT06434779Not ApplicableNot Yet Recruiting

Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)

Role: collaborator

NCT03730571Not ApplicableTerminated

The AbsorbaSeal Vascular Closure Device Trial

Role: lead

NCT04635501Not ApplicableCompleted

AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial

Role: lead

NCT02804113Not ApplicableCompleted

Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery

Role: lead

All 13 trials loaded